03/10/2022
Published by Fondazione Gianni Bonadonna at 03/10/2022
Categories

Neoadjuvant immunotherapy as a promising approach in melanoma and colon cancer

Do you like it?0
Read more
26/09/2022
Published by Fondazione Gianni Bonadonna at 26/09/2022
Categories

Benefits of pralsetinib in patients with RET fusions

Do you like it?0
Read more
19/09/2022
Published by Fondazione Gianni Bonadonna at 19/09/2022
Categories

Outcomes of neoadjuvant durvalumab in triple-negative breast cancer – Experts’ comment

Do you like it?0
Read more
14/09/2022
Published by Fondazione Gianni Bonadonna at 14/09/2022
Categories

Dosing of first three patients in the first-in-human study with selective N-glycosylation inhibitors

Do you like it?0
Read more
05/09/2022
Published by Fondazione Gianni Bonadonna at 05/09/2022
Categories

Positive results with pembrolizumab in advanced triple-negative breast cancer

Do you like it?0
Read more
29/08/2022
Published by Fondazione Gianni Bonadonna at 29/08/2022
Categories

Cancer vaccines, present and future

Do you like it?0
Read more
22/08/2022
Published by Fondazione Gianni Bonadonna at 22/08/2022
Categories

Amcenestrant in post-menopausal women with ER-positive/HER2-negative advanced breast cancer

Do you like it?0
Read more
01/08/2022
Published by Fondazione Gianni Bonadonna at 01/08/2022
Categories

More than 100.000 cases in the AACR Project GENIE

Do you like it?0
Read more
25/07/2022
Published by Fondazione Gianni Bonadonna at 25/07/2022
Categories

Durable clinical benefits in lung cancer with a KRASG12C inhibitor

Do you like it?0
Read more
12345678
Next page
English